Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation

Vascular Pharmacology

Volumn 56, Issue 1-2, 2012, Pages 91-97

  Yoo, Kyu Dong ^a   Park, Eun Seok ^a   Lim, Yong ^b   Kang, Shin Il ^a   Yoo, Su Hyang ^a   Won, Ha Hee ^a   Lee, Hee Pom ^a   Kim, Young Hee ^c   Yoo, Ick Dong ^c   Yoo, Hwan Soo ^a   Hong, Jin Tae ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Dong Eui University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Clitocybin B Clitocybin; PDGF R atherosclerosis; Proliferation; Vascular smooth muscle cell

Indexed keywords

ANTIMITOTIC AGENT; CELL CYCLE PROTEIN; CLITOCYBIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; AORTA; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ISOINDOLES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 84856273142     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.11.004     Document Type: Article

References (32)

1. Braun-Dullaeus R.C., Mann M.J., Sedding D.G., Sherwood S.W., von der Leyen H.E., Dzau V.J. Cell cycle-dependent regulation of smooth muscle cell activation. Arterioscler. Thromb. Vasc. Biol. 2004, 24:845-850.
2. Casscells W. Smooth muscle cell growth factors. Prog. Growth Factor Res. 1991, 3:177-206.
3. Chamley J.H., Campbell G.R., McConnell J.D., Groschel-Stewart U. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res. 1977, 177:503-522.
4. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J. Biol. Chem. 1994, 269:32023-32026.
5. Cui Y., Gutstein W.H., Jabr S., Hsieh T.C., Wu J.M. Control of human vascular smooth muscle cell proliferation by sera derived from 'experimentally stressed' individuals. Oncol. Rep. 1998, 5:1471-1474.
6. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 2002, 8:1249-1256.
7. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4600-4604.
8. Graf K., Xi X.P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 1997, 29:334-339.
9. Gutstein W.H., Teresi J.A., Wu J.M., Ramirez M., Salimian F., Cui Y., Paul I., Jabr S. Increased serum mitogenic activity for arterial smooth muscle cells associated with relaxation and low educational level in human subjects with high but not low hostility traits: implications for atherogenesis. J. Psychosom. Res. 1999, 46:51-61.
10. Heldin C.H., Ostman A., Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1998, 1378:F79-F113.
11. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
12. Hughes A.D., Clunn G.F., Refson J., Demoliou-Mason C. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen. Pharmacol. 1996, 27:1079-1089.
13. Hur K.Y., Seo H.J., Kang E.S., Kim S.H., Song S., Kim E.H., Lim S., Choi C., Heo J.H., Hwang K.C., Ahn C.W., Cha B.S., Jung M., Lee H.C. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury. Eur. J. Pharmacol. 2008, 586:226-233.
14. Jung F., Haendeler J., Goebel C., Zeiher A.M., Dimmeler S. Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc. Res. 2000, 48:148-157.
15. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppanen O., Rosenkranz S., Ostman A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2644-2651.
16. Kim Y.H., Cho S.M., Hyun J.W., Ryoo I.J., Choo S.J., Lee S., Seok S.J., Hwang J.S., Sohn E.D., Yun B.S., Bae K.H., Yoo I.D. A new antioxidant, clitocybin A, from the culture broth of Clitocybe aurantiaca. J. Antibiot. (Tokyo) 2008, 61:573-576.
17. Lyle A.N., Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006, 21:269-280.
18. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 1990, 111:2149-2158.
19. Mercer J., Mahmoudi M., Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat. Res. 2007, 621:75-86.
20. Moon E.Y., Oh J.M., Kim Y.H., Ryoo I.J., Yoo I.D. Clitocybins, novel isoindolinone free radical scavengers, from mushroom Clitocybe aurantiaca inhibit apoptotic cell death and cellular senescence. Biol. Pharm. Bull. 2009, 32:1689-1694.
21. Mulvany M.J. Structure and function of small arteries in hypertension. J. Hypertens. Suppl. 1990, 8:S225-S232.
22. Park E.S., Lim Y., Hong J.T., Yoo H.S., Lee C.K., Pyo M.Y., Yun Y.P. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. Vascul. Pharmacol. 2010, 53:61-67.
23. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 1997, 9:180-186.
24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
25. Rzucidlo E.M., Martin K.A., Powell R.J. Regulation of vascular smooth muscle cell differentiation. J. Vasc. Surg. 2007, 45(Suppl A):A25-A32.
26. Sachinidis A., Locher R., Vetter W., Tatje D., Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J. Biol. Chem. 1990, 265:10238-10243.
27. Sachinidis A., Skach R.A., Seul C., Ko Y., Hescheler J., Ahn H.Y., Fingerle J. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J. 2002, 16:893-895.
28. Sandirasegarane L., Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 2001, 283:158-163.
29. Seo J.M., Jin Y.R., Ryu C.K., Kim T.J., Han X.H., Hong J.T., Yoo H.S., Lee C.K., Yun Y.P. JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations. Biochem. Pharmacol. 2008, 75:1331-1340.
30. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
31. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
32. Yang X., Yang L., Zheng H. Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats. Food Chem Toxicol 2010, 48:2374-2379.